Abstract
Noroviruses are among the most common cause of diarrhea in transplant recipients. The clinical spectrum of norovirus infection after transplant is increasingly being recognized. As substantial morbidity is now associated with norovirus infections in this population; the quest for rapid diagnostic modalities and newer therapies has expanded. Transplant recipients with norovirus infection are at risk for several complications, including protracted illness with malnutrition, organ failure, and chronic viral shedding. This review summarizes the current knowledge on the epidemiology, complications, diagnosis, and treatment of norovirus infection in the transplant setting.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Bresee JS, Marcus R, Venezia RA, Keene WE, Morse D, Thanassi M, et al. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J Infect Dis. 2012;205(9):1374–81.
Hall AJ, Rosenthal M, Gregoricus N, Greene SA, Ferguson J, Henao OL, et al. Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004–2005. Emerg Infect Dis. 2011;17(8):1381–8.
Lopman BA, Hall AJ, Curns AT, Parashar UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996–2007. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2011;52(4):466–74.
Ludwig A, Adams O, Laws HJ, Schroten H, Tenenbaum T. Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus. J Med Virol. 2008;80(8):1461–7.
Saif MA, Bonney DK, Bigger B, Forsythe L, Williams N, Page J, et al. Chronic norovirus infection in pediatric hematopoietic stem cell transplant recipients: a cause of prolonged intestinal failure requiring intensive nutritional support. Pediatr Transplant. 2011;15(5):505–9. This study is provides a case series of norovirus infection in pediatric stem cell recipients and identifies the persistence of viral shedding in these patients as well as the resolution of viral shedding once there is immune reconstitution.
Schorn R, Hohne M, Meerbach A, Bossart W, Wuthrich RP, Schreier E, et al. Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2010;51(3):307–14.
Roddie C, Paul JP, Benjamin R, Gallimore CI, Xerry J, Gray JJ, et al. Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2009;49(7):1061–8.
Schwartz S, Vergoulidou M, Schreier E, Loddenkemper C, Reinwald M, Schmidt-Hieber M, et al. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood. 2011;117(22):5850–6.
Simon A, Schildgen O, Maria Eis-Hubinger A, Hasan C, Bode U, Buderus S, et al. Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol. 2006;41(6):693–9.
Repp KK, Hostetler TP, Keene WE. A norovirus outbreak related to contaminated surfaces. J Infect Dis. 2013;208(2):295–8.
Lopman B, Gastanaduy P, Park GW, Hall AJ, Parashar UD, Vinje J. Environmental transmission of norovirus gastroenteritis. Curr Opin Virol. 2012;2(1):96–102.
Riera-Montes M, Brus Sjolander K, Allestam G, Hallin E, Hedlund KO, Lofdahl M. Waterborne norovirus outbreak in a municipal drinking-water supply in Sweden. Epidemiol Infect. 2011;139(12):1928–35.
Hall AJ, Wikswo ME, Pringle K, Gould LH, Parashar UD, Division of Viral Diseases NCfI, et al. Vital signs: foodborne norovirus outbreaks—United States, 2009-2012. MMWR Morb Mortal Wkly Rep. 2014;63(22):491–5.
Teunis PF, Moe CL, Liu P, Miller SE, Lindesmith L, Baric RS, et al. Norwalk virus: how infectious is it? J Med Virol. 2008;80(8):1468–76.
Verhoef L, Hewitt J, Barclay L, Ahmed SM, Lake R, Hall AJ, et al. Norovirus genotype profiles associated with foodborne transmission, 1999-2012. Emerg Infect Dis. 2015;21(4):592–9.
Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinje J. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis. 2011;17(8):1389–95.
Centers for Disease C, Prevention. Emergence of new norovirus strain GII.4 Sydney—United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(3):55.
Yen C, Wikswo ME, Lopman BA, Vinje J, Parashar UD, Hall AJ. Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2011;53(6):568–71.
Gastanaduy PA, Hall AJ, Curns AT, Parashar UD, Lopman BA. Burden of norovirus gastroenteritis in the ambulatory setting—United States, 2001-2009. J Infect Dis. 2013;207(7):1058–65.
Patel MM, Hall AJ, Vinje J, Parashar UD. Noroviruses: a comprehensive review. J Clin Virol. 2009;44(1):1–8.
Robilotti E, Deresinski S, Pinsky BA. Norovirus. Clin Microbiol Rev. 2015;28(1):134–64.
Rockx B, De Wit M, Vennema H, Vinje J, De Bruin E, Van Duynhoven Y, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis. 2002;35(3):246–53.
Roos-Weil D, Ambert-Balay K, Lanternier F, Mamzer-Bruneel MF, Nochy D, Pothier P, et al. Impact of norovirus/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation. 2011;92(1):61–9.
Florescu DF, Hill LA, McCartan MA, Grant W. Two cases of Norwalk virus enteritis following small bowel transplantation treated with oral human serum immunoglobulin. Pediatr Transplant. 2008;12(3):372–5.
Lee BE, Pang XL, Robinson JL, Bigam D, Monroe SS, Preiksaitis JK. Chronic norovirus and adenovirus infection in a solid organ transplant recipient. Pediatr Infect Dis J. 2008;27(4):360–2.
Ye X, Van JN, Munoz FM, Revell PA, Kozinetz CA, Krance RA, et al. Noroviruses as a cause of diarrhea in immunocompromised pediatric hematopoietic stem cell and solid organ transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(7):1874–81.
Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med. 2012;367(22):2126–32.
Chehade H, Girardin E, Delich V, Pascual MA, Venetz JP, Cachat F. Acute norovirus-induced agranulocytosis in a pediatric kidney transplant recipient. Transpl Infect Dis: Off J Transpl Soc. 2012;14(4):E27–9.
Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect. 2000;124(3):481–7.
Marks PJ, Vipond IB, Regan FM, Wedgwood K, Fey RE, Caul EO. A school outbreak of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect. 2003;131(1):727–36.
Doshi M, Woodwell S, Kelleher K, Mangan K, Axelrod P. An outbreak of norovirus infection in a bone marrow transplant unit. Am J Infect Control. 2013;41(9):820–3.
Khare R, Espy MJ, Cebelinski E, Boxrud D, Sloan LM, Cunningham SA, et al. Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens. J Clin Microbiol. 2014;52(10):3667–73.
http://www.accessdata.fda.gov/cdrh_docs/pdf14/K142501.pdf. X pert Norovirus assay 2014.
Buchan Blake RK. Ledeboer Nathan Evaluation of the verigene enteric pathogens (EP) nucleic acid tests for the identification of bacterial and viral agents of diarrhoea directly from stool specimens. 25 th ECCMID Coenhagen, Denmark, 2015. 12:30–13:30.
Vega E, Donaldson E, Huynh J, Barclay L, Lopman B, Baric R, et al. RNA populations in immunocompromised patients as reservoirs for novel norovirus variants. J Virol. 2014;88(24):14184–96.
Debbink K, Lindesmith LC, Ferris MT, Swanstrom J, Beltramello M, Corti D, et al. Within-host evolution results in antigenically distinct GII.4 noroviruses. J Virol. 2014;88(13):7244–55.
Rossignol JF. Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antivir Res. 2014;110:94–103.
Rossignol JF, El-Gohary YM. Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. Aliment Pharmacol Ther. 2006;24(10):1423–30. First description of treatment of norovirus with nitazoxanide. This is a promising agent that is a needed treatment addition for norovirus infection.
Siddiq DM, Koo HL, Adachi JA, Viola GM. Norovirus gastroenteritis successfully treated with nitazoxanide. J Infect. 2011;63(5):394–7.
Gairard-Dory AC, Degot T, Hirschi S, Schuller A, Leclercq A, Renaud-Picard B, et al. Clinical usefulness of oral immunoglobulins in lung transplant recipients with norovirus gastroenteritis: a case series. Transplant Proc. 2014;46(10):3603–5. Case series of 12 patients with lung transplant and norovirus treated with oral immune globulins. 11 patients where successfully treated. A possible treatment option for patients with persistent or severe norovirus infetcion.
Webster AC, Lee VW, Chapman JR, Craig JC. Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials. Transplantation. 2006;81(9):1234–48.
Boillat Blanco N, Kuonen R, Bellini C, Manuel O, Estrade C, Mazza-Stalder J, et al. Chronic norovirus gastroenteritis in a double hematopoietic stem cell and lung transplant recipient. Transplant Infect Dis: Off J Transplant Soc. 2011;13(2):213–5.
Engelen MA, Gunia S, Stypmann J. Elimination of norovirus in a chronic carrier under immunosuppression after heart transplantation—effect of everolimus. Transplant Int: Off J Eur Soc Organ Transplant. 2011;24(11):e102–3.
Division of Viral Diseases NCfI, Respiratory Diseases CfDC, Prevention. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recommendations and reports: morbidity and mortality weekly report Recommendations and reports. Centers Dis Control. 2011;60(RR-3):1–18.
Tuladhar E, Hazeleger WC, Koopmans M, Zwietering MH, Duizer E, Beumer RR. Reducing viral contamination from finger pads: handwashing is more effective than alcohol-based hand disinfectants. J Hosp Infect. 2015;90(3):226–34.
Liu P, Yuen Y, Hsiao HM, Jaykus LA, Moe C. Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol. 2010;76(2):394–9.
Siegel J, Rhinehart E, Jackson M, Chiarello L, Committee HICPA. Guidelines for isolation precautions: preventing transmission of infectious agents in healthcare settings http://www.cdc.gov/hicpac/2007IP/2007isolationPrecautions.html. 2007.
Ueda R, Fuji S, Mori S, Hiramoto N, Hashimoto H, Tanaka T, et al. Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography. Int J Hematol. 2015;102(1):121–8.
Lemes LG, Correa TS, Fiaccadori FS, Cardoso D, Arantes Ade M, Souza KM, et al. Prospective study on Norovirus infection among allogeneic stem cell transplant recipients: prolonged viral excretion and viral RNA in the blood. J Clin Virol: Off Publ Pan Am Soc Clin Virol. 2014;61(3):329–33.
Robles JD, Cheuk DK, Ha SY, Chiang AK, Chan GC. Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplant. 2012;18(12):1883–9.
Chagla Z, Quirt J, Woodward K, Neary J, Rutherford C. Chronic norovirus infection in a transplant patient successfully treated with enterally administered immune globulin. J Clin Virol. 2013;58(1):306–8.
Woodward JM, Gkrania-Klotsas E, Cordero-Ng AY, Aravinthan A, Bandoh BN, Liu H, et al. The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. Am J Gastroenterol. 2015;110(2):320–7.
Henke-Gendo C, Harste G, Juergens-Saathoff B, Mattner F, Deppe H, Heim A. New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children. J Clin Microbiol. 2009;47(9):2855–62.
Xerry J, Gallimore CI, Cubitt D, Gray JJ. Tracking environmental norovirus contamination in a pediatric primary immunodeficiency unit. J Clin Microbiol. 2010;48(7):2552–6.
Bull RA, Eden JS, Luciani F, McElroy K, Rawlinson WD, White PA. Contribution of intra- and interhost dynamics to norovirus evolution. J Virol. 2012;86(6):3219–29.
Sheahan A, Copeland G, Richardson L, McKay S, Chou A, Babady NE, et al. Control of norovirus outbreak on a pediatric oncology unit. Am J Infect Control. 2015;43(10):1066–9. Excellent assessment of infection control measures needed to help control a norovirus outbreak on a pediatric oncology unit. Use of recommended CDC control measures with electronic surveillance, screening for norovirus and heightened cleaning led to resolution of the outbreak.
Sukhrie FH, Teunis P, Vennema H, Copra C, Thijs Beersma MF, Bogerman J, et al. Nosocomial transmission of norovirus is mainly caused by symptomatic cases. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2012;54(7):931–7.
Sukhrie FH, Siebenga JJ, Beersma MF, Koopmans M. Chronic shedders as reservoir for nosocomial transmission of norovirus. J Clin Microbiol. 2010;48(11):4303–5.
Echenique IA, Penugonda S, Stosor V, Ison MG, Angarone MP. Diagnostic yields in solid organ transplant recipients admitted with diarrhea. Clin Infect Dis: Off Publ Infect Dis Soc Am. 2015;60(5):729–37.
Ebdrup L, Bottiger B, Molgaard H, Laursen AL. Devastating diarrhoea in a heart-transplanted patient. J Clin Virol: Off Publ Pan Am Soc Clin Virol. 2011;50(4):263–5.
Echenique IA, Stosor V, Gallon L, Kaufman D, Qi C, Zembower TR. Prolonged norovirus infection after pancreas transplantation: a case report and review of chronic norovirus. Transpl Infect Dis. 2015. Very well described case of extremely prolonged norovirus shedding with persistent diarrheal symptoms. This case also describes the genetic changes norovirus can undergo in the same patient.
Nilsson M, Hedlund KO, Thorhagen M, Larson G, Johansen K, Ekspong A, et al. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol. 2003;77(24):13117–24.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Drs Angarone, Sheahan, and Kamboj declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Financial Disclosures
This study was funded by the MSK Cancer Center Core Grant (P30 CA008748).
Additional information
This article is part of the Topical Collection on Transplant and Oncology
Rights and permissions
About this article
Cite this article
Angarone, M.P., Sheahan, A. & Kamboj, M. Norovirus in Transplantation. Curr Infect Dis Rep 18, 17 (2016). https://doi.org/10.1007/s11908-016-0524-y
Published:
DOI: https://doi.org/10.1007/s11908-016-0524-y